MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1164/rccm.200811-1704oc

Медицинская библиотека · American journal of respiratory and critical care medicine · 2009

Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing.

van Zyl-Smit Richard N, Pai Madhukar, Peprah Kwaku, Meldau Richard, Kieck Jackie, Juritz June, Badri Motasim, Zumla Alimuddin, Sechi Leonardo A, Bateman Eric D, Dheda Keertan

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

RATIONALE: The optimal strategy for the diagnosis of latent tuberculosis infection is controversial. Adoption of a two-step strategy (tuberculin skin test [TST] followed by an IFN-gamma release assay [IGRA], compared with an IGRA alone), may be limited by TST-mediated boosting of subsequent IGRA responses. Assessment of within-subject IGRA variability will aid in establishing thresholds for conversions and reversions, and interpretation of serial testing results.

OBJECTIVES

To determine short-term IGRA variability and the impact of TST on subsequent IGRA results.

METHODS

Within-subject variability and TST-mediated boosting of IGRA responses were evaluated in 26 South African participants with varying exposure risk. IGRAs (T-SPOT.TB, QuantiFERON-TB Gold In-Tube [QuantiFERON-TB-GIT], PPD, and heparin-binding hemagglutinin) were repeated four times over 21 days pre-TST, and on Days 3, 7, 28, and 84 post-TST administration.

MEASUREMENTS AND MAIN

RESULTS

All participants showed within-subject IGRA variability. Changes of +/-3 spots (T-SPOT.TB) or +/-80% from the mean IFN-gamma response (QuantiFERON-TB-GIT) over 3 weeks explained 95% of the variability. Spontaneous conversions/reversions occurred in 7 of 26 subjects (27%) (6 for T-SPOT.TB and 1 for QuantiFERON-TB-GIT [P = 0.049]) during the within-patient variability studies (pre-TST). After the TST eight subjects (33%) boosted above the defined baseline variability. By Day 7 post-TST, but not Day 3, 2 (12.5%) initially IGRA-negative test subjects converted. By contrast, boosting of PPD and heparin-binding hemagglutinin occurred by Day 3 post-TST.

CONCLUSIONS

When using a two-step screening strategy it appears safe to perform a QuantiFERON-TB-GIT or T-SPOT.TB IGRA within 3 days of performing the TST. A 3-spot or 80% IFN-gamma response variation, on either side of baseline values, explains 95% of the short-term variability and may be useful for interpreting conversions and reversions, and values close to the cut-point.

Для цитирования: van Zyl-Smit Richard N, Pai Madhukar, Peprah Kwaku, Meldau Richard, Kieck Jackie, Juritz June, Badri Motasim, Zumla Alimuddin, Sechi Leonardo A, Bateman Eric D, Dheda Keertan. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing.. American journal of respiratory and critical care medicine. 2009. DOI: 10.1164/rccm.200811-1704oc.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.